MabVax Therapeutics Holdings Inc.

(: MBVXQ)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

MabVax Therapeutics Holdings Inc is a development-stage biopharmaceutical company works to discover, develop, and commercialize small molecule drugs to treat cancer-related illnesses. The company has discovered a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been vaccinated against targeted cancers with theie proprietary vaccines. Its pipeline include Therapeutic(MVT-5873), Radioimmunotherapy(MVT-1075), HuMab-Tn and others.

Contact Information

Website: www.mabvax.com
Email: investors@telik.com
Main Phone: +1 858 259-9405
Address: 11535 Sorrento Valley Road
Address 2: Suite 400
State: CA
City / Town: San Diego
Country: US
Postal Code: 92121

Issuer Information

Exchange: OTO
CEO: J. David Hansen
Employees: 6
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A